Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Soligenix Inc (SNGX)

1.71 -0.09 (-5%)

04-20 16:00

Open:

1.79

Pre. Close:

1.8

High:

1.79

Low:

1.6995

Volume:

12,138

Market Cap:

15M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

1.793 - 1.802

1.802 - 1.809

Low:

1.68 - 1.689

1.689 - 1.697

Close:

1.696 - 1.711

1.711 - 1.723

Technical analysis  (as of: 2018-04-20 4:33:41 PM)

Overall:

      

Stoxline posted a NEUTRAL today, same as yesterday. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next Buy or SELL signal.

Target:

Six months: 3.38     One year: 4.32

Support:

Support1: 1.60    Support2: 1.33

Resistance:

Resistance1: 2.90    Resistance2: 3.70

Pivot:

1.81

Moving Averages:

MA(5): 1.76     MA(20): 1.85

MA(100): 2.04     MA(250): 2.19

MACD:

MACD(12,26): -0.07     Signal(12,26,9): -0.06

%K %D:

%K(14,3): 35.19     %D(3): 35.47

RSI:

RSI(14): 37.03

52-Week:

High: 4.4  Low: 1.6  Change(%): -56.5

Average Vol(K):

3-Month: 15995  10-Days 2814

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
SNGX has closed above bottom band by 8.3%. Bollinger Bands are 19.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2018-03-23T00:49:21-04:00
Your Daily Pharma Scoop: Omeros' Omidria, Titan Signs Agreement, Reata Announces Top-Line Results

2018-03-22T12:45:06-04:00
Midday Gainers / Losers (03/22/2018)

2018-03-22T09:11:54-04:00
Premarket Gainers as of 9:05 am (03/22/2018)

2018-03-22T06:58:43-04:00
Soligenix's RiVax an Orphan Drug in Europe

2018-03-22T06:00:00-04:00
Soligenix Receives Orphan Drug Designation from the European Commission for RiVax® for Prevention of Ricin Poisoning

2018-03-15T06:07:20-04:00
Soligenix reports FY results

2018-03-15T06:00:00-04:00
Soligenix Announces Recent Accomplishments And Year-End 2017 Financial Results

2018-03-13T06:00:00-04:00
Soligenix to Present at the 12th Annual International Partnering Conference Bio-Europe Spring

Financial Analysis

Growth

NA

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

NA

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

NA

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  0

Industry:  0

Shares Out. (M)

8.74

Shares Float (M)

1.34

% Held by Insiders

84.80

% Held by Institutions

22.50

Shares Short (K)

378

Shares Short Prior Month (K)

421

Stock Financials

EPS

EPS Est. Current Year

-1.480

EPS Est. Next Year

-1.470

EPS Est. Next Quarter

-0.340

Forward EPS

-1.200

Book Value (p.s.)

2.390

PEG Ratio

Profit Margin

Operating Margin

-139.79

Return on Assets (ttm)

-72.1

Return on Equity (ttm)

-104.2

Qtrly Rev. Growth

-24.1

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

Qtrly Earnings Growth

Operating Cash Flow (M)

-6.51

Levered Free Cash Flow (M)

-4.11

atoplab.com

Valuation

P/E

P/E Growth Ratio

P/BV

0.72

P/S

16983410.00

P/CF

-2.30

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

2016-10-07

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.